as 07-26-2024 4:00pm EST
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Founded: | 1994 | Country: | United States |
Employees: | N/A | City: | ALHAMBRA |
Market Cap: | 1.8B | IPO Year: | N/A |
Target Price: | $50.67 | AVG Volume (30 days): | 246.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.32 | EPS Growth: | 36.08 |
52 Week Low/High: | $28.87 - $54.27 | Next Earning Date: | 08-07-2024 |
Revenue: | $1,453,774,000 | Revenue Growth: | 19.34% |
Revenue Growth (this year): | 28.58% | Revenue Growth (next year): | 21.70% |
ASTH Breaking Stock News: Dive into ASTH Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
PR Newswire
3 days ago
PR Newswire
9 days ago
Simply Wall St.
9 days ago
Argus Research
10 days ago
PR Newswire
11 days ago
Argus Research
17 days ago
Simply Wall St.
2 months ago
The information presented on this page, "ASTH Astrana Health Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.